| Name | Title | Type |
|---|---|---|
| Brian Landsman | Cfo | Auditee |
| Fabio Alvarez | Chief Financial Officer | Auditee |
| Marianne Gribbon | CEO | Auditee |
| Alan W. Clink, CPA | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 366307 | 2024 | 2025-09-15 | Mengel Metzger Barr & CO LLP | $3.97M |
| 335657 | 2023 | 2025-01-03 | Mengel Metzger Barr & CO LLP | $3.19M |
| 326861 | 2022 | 2024-10-31 | Mengel Metzger Barr & CO LLP | $3.05M |
| 296079 | 2021 | 2024-03-20 | Mengel Metzger Barr & CO LLP | $2.78M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 366307 | 2024 | 2025-09-15 | 1153056 | 2024-007 | Material Weakness | Yes | A |
| 366307 | 2024 | 2025-09-15 | 1153055 | 2024-007 | Material Weakness | Yes | A |
| 366307 | 2024 | 2025-09-15 | 1153054 | 2024-006 | Material Weakness | Yes | L |
| 366307 | 2024 | 2025-09-15 | 1153053 | 2024-006 | Material Weakness | Yes | L |
| 366307 | 2024 | 2025-09-15 | 1153052 | 2024-005 | Material Weakness | Yes | L |
| 366307 | 2024 | 2025-09-15 | 1153051 | 2024-005 | Material Weakness | Yes | L |
| 335657 | 2023 | 2025-01-03 | 1094057 | 2023-007 | Material Weakness | Yes | A |
| 335657 | 2023 | 2025-01-03 | 1094056 | 2023-007 | Material Weakness | Yes | A |
| 335657 | 2023 | 2025-01-03 | 1094055 | 2023-006 | Significant Deficiency | Yes | L |
| 335657 | 2023 | 2025-01-03 | 1094054 | 2023-006 | Significant Deficiency | Yes | L |
| 335657 | 2023 | 2025-01-03 | 1094053 | 2023-005 | Significant Deficiency | Yes | L |
| 335657 | 2023 | 2025-01-03 | 1094052 | 2023-005 | Significant Deficiency | Yes | L |
| 335657 | 2023 | 2025-01-03 | 517615 | 2023-007 | Material Weakness | Yes | A |
| 335657 | 2023 | 2025-01-03 | 517614 | 2023-007 | Material Weakness | Yes | A |
| 335657 | 2023 | 2025-01-03 | 517613 | 2023-006 | Significant Deficiency | Yes | L |
| 335657 | 2023 | 2025-01-03 | 517612 | 2023-006 | Significant Deficiency | Yes | L |
| 335657 | 2023 | 2025-01-03 | 517611 | 2023-005 | Significant Deficiency | Yes | L |
| 335657 | 2023 | 2025-01-03 | 517610 | 2023-005 | Significant Deficiency | Yes | L |
| 326861 | 2022 | 2024-10-31 | 1080756 | 2022-008 | Material Weakness | Yes | A |
| 326861 | 2022 | 2024-10-31 | 1080755 | 2022-008 | Material Weakness | Yes | A |
| 326861 | 2022 | 2024-10-31 | 1080754 | 2022-007 | Significant Deficiency | Yes | L |
| 326861 | 2022 | 2024-10-31 | 1080753 | 2022-007 | Significant Deficiency | Yes | L |
| 326861 | 2022 | 2024-10-31 | 1080752 | 2022-006 | Significant Deficiency | Yes | L |
| 326861 | 2022 | 2024-10-31 | 1080751 | 2022-006 | Significant Deficiency | Yes | L |
| 326861 | 2022 | 2024-10-31 | 504314 | 2022-008 | Material Weakness | Yes | A |
| 326861 | 2022 | 2024-10-31 | 504313 | 2022-008 | Material Weakness | Yes | A |
| 326861 | 2022 | 2024-10-31 | 504312 | 2022-007 | Significant Deficiency | Yes | L |
| 326861 | 2022 | 2024-10-31 | 504311 | 2022-007 | Significant Deficiency | Yes | L |
| 326861 | 2022 | 2024-10-31 | 504310 | 2022-006 | Significant Deficiency | Yes | L |
| 326861 | 2022 | 2024-10-31 | 504309 | 2022-006 | Significant Deficiency | Yes | L |
| 296079 | 2021 | 2024-03-20 | 958819 | 2021-009 | Material Weakness | Yes | B |
| 296079 | 2021 | 2024-03-20 | 958818 | 2021-009 | Material Weakness | Yes | B |
| 296079 | 2021 | 2024-03-20 | 958817 | 2021-008 | Significant Deficiency | Yes | L |
| 296079 | 2021 | 2024-03-20 | 958816 | 2021-008 | Significant Deficiency | Yes | L |
| 296079 | 2021 | 2024-03-20 | 958815 | 2021-007 | Significant Deficiency | Yes | L |
| 296079 | 2021 | 2024-03-20 | 958814 | 2021-007 | Significant Deficiency | Yes | L |
| 296079 | 2021 | 2024-03-20 | 958813 | 2021-006 | Significant Deficiency | Yes | I |
| 296079 | 2021 | 2024-03-20 | 958812 | 2021-006 | Significant Deficiency | Yes | I |
| 296079 | 2021 | 2024-03-20 | 382377 | 2021-009 | Material Weakness | Yes | B |
| 296079 | 2021 | 2024-03-20 | 382376 | 2021-009 | Material Weakness | Yes | B |
| 296079 | 2021 | 2024-03-20 | 382375 | 2021-008 | Significant Deficiency | Yes | L |
| 296079 | 2021 | 2024-03-20 | 382374 | 2021-008 | Significant Deficiency | Yes | L |
| 296079 | 2021 | 2024-03-20 | 382373 | 2021-007 | Significant Deficiency | Yes | L |
| 296079 | 2021 | 2024-03-20 | 382372 | 2021-007 | Significant Deficiency | Yes | L |
| 296079 | 2021 | 2024-03-20 | 382371 | 2021-006 | Significant Deficiency | Yes | I |
| 296079 | 2021 | 2024-03-20 | 382370 | 2021-006 | Significant Deficiency | Yes | I |